Global Information
회사소개 | 문의 | 비교리스트

세계의 펨테크(Femtech) 시장 : 분석과 예측(2019-2030년)

Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030

리서치사 BIS Research Inc.
발행일 2020년 06월 상품 코드 941003
페이지 정보 영문
가격
US $ 5,000 ₩ 6,078,000 Unprintable PDF by E-mail (Single User License)
US $ 5,500 ₩ 6,685,000 Hard Copy
US $ 6,500 ₩ 7,901,000 Printable PDF by E-mail (Single Site License)
US $ 8,000 ₩ 9,724,000 Printable PDF and Excel by E-mail (Enterprise-wide License)


세계의 펨테크(Femtech) 시장 : 분석과 예측(2019-2030년) Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030
발행일 : 2020년 06월 페이지 정보 : 영문

세계의 펨테크(Femtech : Female Technology) 시장 규모는 2019년에 8억 2060만 달러로 추계되며, 예측 기간 중 12.65%의 성장이 전망됩니다. 시장의 주요 촉진요인 중 하나는 여성의 감염증 및 만성질환 발생률 증가로, 효과적인 맞춤형 치료의 수요가 급증하고 있습니다. 또한 최근 여성의 건강 인식은 대폭 높아지고 있습니다.

세계의 펨테크(Femtech) 시장에 대해 분석했으며, 시장 역학, 경쟁 환경, 각 부문·지역별 시장, 경쟁 구도 및 주요 기업 등에 관한 상세 분석을 정리하여 전해드립니다.

제1장 제품 정의

제2장 조사 범위

제3장 조사 방법

  • 1차 데이터 소스
  • 2차 데이터 소스
  • 시장 예측 모델
  • 조사 대상 기업
  • 전제조건과 제한사항

제4장 산업 분석

  • 업계 동향
    • 의사결정자로서 여성의 과소평가
    • 가격과 브랜드 전략
    • 신흥 경제국의 펨테크
    • 종합적 여성 헬스케어의 중요성 증가
    • 스마트 의료기기와 웨어러블
    • 월경과 갱년기 장애는 부끄러운 것이 아니다.
  • 펨테크 이노베이션 트래커
    • 수태력 추적을 위한 웨어러블 디바이스
    • 생식 주기 모니터링을 위한 질센서
    • 게노믹스와 빅데이터를 활용한 수태력 추적과 월경 건강
    • 유방암 검진용 웨어러블
  • 규제 프레임워크
    • 북미의 규제 프레임워크
    • 유럽의 규제 구조
  • 자금 분석
    • 펨테크는 과거 5년간 10억 달러 이상을 획득
    • 펨테크의 주목 민간 자금

제5장 경쟁 구도

  • 주요 발전과 전략
    • 자금
    • 협업과 파트너십
    • 제품 발매와 업그레이드
    • 합병과 인수
  • 비지니스 모델 분석
    • One-for-One Give Back 모델
    • 직판
    • 서브스크립션
    • 처방약 원격의료 모델
  • 제품 지도제작 분석

제6장 시장 역학

  • 시장 성장 촉진요인
    • 기술 영역에서 여성의 인식 향상
    • 여성 건강에 의한 경제적 부담은 5,000억 달러 이상
    • 웨어러블 디바이스의 폭발적 증가와 여성 사이에서 스마트폰의 보급률 증가
  • 시장 성장 억제요인
    • 여성 의사결정자의 부족
    • 여성 건강 문제를 둘러싼 사회적 터부
    • 농촌 지역에서 여성 인식의 결여
    • 업계의 주장을 증명하는 과학적 연구의 결여
    • 자본과 노동력의 증가
    • 펨테크 영역의 제품 마케팅
  • 시장 기회
    • 임산부, 출생전 및 신생아 케어를 위한 제품 개발에 대한 투자
    • 사하라 이남 아프리카에 대한 투자
    • 갱년기 장애 관리를 위한 제품 개발

제7장 세계의 펨테크 시장

  • 전제조건과 제한사항
  • 주요 조사 결과와 기회 평가
    • 주요 조사 결과
    • 시장 기회 평가

제8장 세계의 펨테크 시장(컴포넌트별)

  • 개요
  • 모바일 앱
  • 커넥티드 디바이스
    • 웨어러블 커넥티드 디바이스
    • 비웨어러블 커넥티드 디바이스
  • 서비스
  • 기타(오가닉, 스마트 여성용 위생용품)

제9장 세계의 펨테크 시장(애플리케이션별)

  • 개요
  • 생식건강
    • 주기 추적
    • 가정에서의 수태력 추적·모니터링
  • 일반적인 웰니스
  • 임신과 간호
    • 임신중 케어
    • 임신 후 케어
    • 모유수유
    • 기타
  • 골반과 자궁 케어
    • 골반 웰니스
    • 월경 건강

제10장 세계의 펨테크 시장(최종사용자)

  • 개요
  • 개인
  • 불임 치료 클리닉
  • 병원·연구기관
  • 진단 센터

제11장 세계의 펨테크 시장(지역별)

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 스웨덴
    • 스페인
    • 프랑스
    • 네덜란드
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 호주
    • 인도
    • 기타
  • 중동, 남아프리카, 라틴아메리카
    • 중동
    • 남아프리카공화국
    • 라틴아메리카
    • 기타

제12장 기업 개요

  • 개요
  • ALYK, Inc.
  • Aytu BioScience, Inc.
  • Biowink GmbH
  • Bloomlife
  • CORA
  • Flo Health, Inc.
  • Glow, Inc.
  • Inne
  • Kasha
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • Sustain Natural
  • The Flex Company
  • Thinx, Inc.
  • 기업 스냅숏
    • Celmatix Inc.
    • Conceivable Inc.
    • Lia Diagnostics Inc.
    • Lucina Health, Inc.(Unified Women's Healthcare, LLC의 자회사)
    • Progny, Inc.
    • Univfy Inc.
KSA 20.06.26

List of Tables

  • Table 1: Some of the largest rounds of funding received by Femtech companies in 2019 include:
  • Table 2: Global Femtech Market (by End User), $Million, 2019-2030
  • Table 4.1: Pricing and Branding Strategy in the Global Femtech Market
  • Table 4.2: Celmatix, Inc: Product Portfolio
  • Table 4.3: Regulatory Framework for Femtech Market in North America
  • Table 4.4: Regulatory Framework for Femtech Market in Europe
  • Table 4.5: Venture Capital Firms for Women Health
  • Table 4.6: Private Funding in Global Femtech Market, 2019
  • Table 5.1: Global Femtech Market, Products
  • Table 6.1: Prevalence of Diseases in Women, 2017
  • Table 6.2: Global Mobile Phone Adoption by Women
  • Table 8.1: Mobile Applications for Women Reproductive Health
  • Table 8.1: Femtech Integration in Fertility Treatment
  • Table 9.1: Competitive Analysis
  • Table 9.2: Leading Products
  • Table 9.3: The size of healthcare burden of certain conditions that can be attributed to Menopause
  • Table 9.4: Wearables for Pregnancy Care
  • Table 9.5: Leading Solutions Developed by Healthcare Organizations for Gestational Diabetes Mellitus (GDM) Monitoring
  • Table 9.6: Salient Features of Freely Available Mobile Apps That Help Women to Ease into Postpartum
  • Table 10.1: Privacy Policy Analysis
  • Table 11.1: Breakdown of Funding Under National Women's Health Strategy 2020-2030
  • Table 11.2: Other Innovative Femtech Start-Ups in Israel

List of Figures

  • Figure 1: Global Female Income to Reach $26 Trillion by the End of 2020
  • Figure 2: Average Health Spending by Age and Gender, 2016
  • Figure 3: Global Femtech Market, $Million, 2018-2030
  • Figure 4: Global Femtech Market (by Component Type), Percent Share (%), 2019 and 2030
  • Figure 5: Global Femtech Market (by Region), $Million, 2019, 2025 and 2030
  • Figure 2.1: Global Femtech Market Segmentation
  • Figure 3.1: Global Femtech Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Venture Capital Firms Deal Count, 2008-2018
  • Figure 5.1: Share of Key Developments and Strategies, January 2016-March 2020
  • Figure 5.2: Funding Activity Share (by Company), January 2016-March 2020
  • Figure 5.3: Collaborations and Partnerships Share (by Company), January 2016-March 2020
  • Figure 5.4: Product Launches (by Company), January 2016-March 2020
  • Figure 5.5: Mergers and Acquisitions (by Company), January 2016- March 2020
  • Figure 5.6: Global Femtech Market, Product Mapping Analysis, 2019
  • Figure 6.1: Women Health Expenditure in the U.S., $Million, 2016-2020
  • Figure 6.2: Global Wearable Device Adoption by Women, 2018
  • Figure 8.1: Global Femtech Market (by Component)
  • Figure 8.2: Global Femtech Market (Apps), 2018-2030
  • Figure 8.3: Workflow in a Period Tracking Application
  • Figure 8.4: Global Femtech Market (Connected Devices), 2018-2030
  • Figure 8.5: Global Femtech Market (Services), 2018-2030
  • Figure 8.6: Global Femtech Market (Others), 2018-2030
  • Figure 9.1: Global Femtech Market (by Application)
  • Figure 9.2: Global Femtech Market (Reproductive Health), 2018-2030
  • Figure 9.3: Global Femtech Market (General Wellness), 2018-2030
  • Figure 9.4: Global Femtech Market (Pregnancy and Nursing Care), 2018-2030
  • Figure 9.5: Global Femtech Market (Pelvic and Uterine Care), 2018-2030
  • Figure 10.1: Global Femtech Market ( Individual Users), 2018-2030
  • Figure 10.2: Global Femtech Market (Fertility Clinics), 2018-2030
  • Figure 10.3: Global Femtech Market (Hospitals and Research Institutes), 2018-2030
  • Figure 10.4: Global Femtech Market (Diagnostic Centers), 2018-2030
  • Figure 11.1: Global Femtech Market (by Region)
  • Figure 11.2: North America Femtech Market, 2018-2030
  • Figure 11.3: North America: Market Dynamics
  • Figure 11.4: U.S. Femtech Market, 2018-2030
  • Figure 11.5: Canada Femtech Market, 2018-2030
  • Figure 11.6: Europe Femtech Market, 2018-2030
  • Figure 11.7: Europe: Market Dynamics
  • Figure 11.8: Germany Femtech Market, 2018-2030
  • Figure 11.9: U.K. Femtech Market, 2018-2030
  • Figure 11.10: Sweden Femtech Market, 2018-2030
  • Figure 11.11: Spain Femtech Market, 2018-2030
  • Figure 11.12: France Femtech Market, 2018-2030
  • Figure 11.13: Netherlands Femtech Market, 2018-2030
  • Figure 11.14: Rest-of-Europe Femtech Market, 2018-2030
  • Figure 11.15: Asia-Pacific Femtech Market, 2018-2030
  • Figure 11.16: Asia-Pacific: Market Dynamics
  • Figure 11.17: China Femtech Market, 2018-2030
  • Figure 11.18: Japan Femtech Market, 2018-2030
  • Figure 11.19: South Korea Femtech Market, 2018-2030
  • Figure 11.20: Australia Femtech Market, 2018-2030
  • Figure 11.21: India Femtech Market, 2018-2030
  • Figure 11.22: Rest-of-Asia-Pacific Femtech Market, 2018-2030
  • Figure 11.23: Rest-of-the-World Femtech Market, 2018-2030
  • Figure 11.24: Middle East, Africa, and Latin America: Market Dynamics
  • Figure 11.25: Israel Femtech Market, 2018-2030
  • Figure 11.26: Saudi Arabia Femtech Market, 2018-2030
  • Figure 11.27: UAE Femtech Market, 2018-2030
  • Figure 11.28: South Africa Femtech Market, 2018-2030
  • Figure 11.29: Brazil Femtech Market, 2018-2030
  • Figure 11.30: Mexico Femtech Market, 2018-2030
  • Figure 11.31: Rest-of-RoW Femtech Market, 2018-2030
  • Figure 12.1: ALYK, Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.2: ALYK,Inc.: SWOT Analysis
  • Figure 12.3: Aytu Bioscience, Inc.: Product Portfolio for Global Femtech Market
  • Figure 12.4: Aytu Bioscience: Overall Financials, 2016-2018
  • Figure 12.5: Aytu Bioscience, Inc. Revenue (by Region), 2017-2018
  • Figure 12.6: Aytu Bioscience, Inc. R&D Expenditure, 2016-2018
  • Figure 12.7: Aytu Bioscience, Inc: SWOT Analysis
  • Figure 12.8: Biowink GmbH: Product Portfolio for the Global Femtech Market
  • Figure 12.9: Biowink GmbH.: SWOT Analysis
  • Figure 12.10: Bloomlife: Product Portfolio for the Global Femtech Market
  • Figure 12.11: Bloomlife.: SWOT Analysis
  • Figure 12.12: CORA.: Product Portfolio for the Global Femtech Market
  • Figure 12.13: CORA SWOT Analysis
  • Figure 12.14: Flo Health Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.15: Flo Health Inc.: SWOT Analysis
  • Figure 12.16: Glow, Inc.: Product Portfolio for the Global Femtech Market
  • Figure 12.17: Glow, Inc.: SWOT Analysis
  • Figure 12.18: Inne.: Product Portfolio for the Global Femtech Market
  • Figure 12.19: Inne. SWOT Analysis
  • Figure 12.20: Kasha.: Product Portfolio for the Global Femtech Market
  • Figure 12.21: Kasha SWOT Analysis
  • Figure 12.22: NaturalCycles Nordic AB.: Product Portfolio for the Global Femtech Market
  • Figure 12.23: NaturalCycels Nordic AB: SWOT Analysis
  • Figure 12.24: Ovia Health.: Product Portfolio for the Global Femtech Market
  • Figure 12.25: Ovia Health: SWOT Analysis
  • Figure 12.26: Plackal Tech: Product Portfolio for the Global Femtech Market
  • Figure 12.27: Plackal Tech.: SWOT Analysis
  • Figure 12.28: Sustain Natural.: Product Portfolio for the Global Femtech Market
  • Figure 12.29: Sustain Natural SWOT Analysis
  • Figure 12.30: The Flex Company.: Product Portfolio for the Global Femtech Market
  • Figure 12.31: The Flex Company SWOT Analysis
  • Figure 12.32: Thinx Inc..: Product Portfolio for the Global Femtech Market
  • Figure 12.33: Thinx Inc. SWOT Analysis

“Global Femtech Market to Reach $3.04 Billion by 2030.”

Market Segmentation

  • Component - Mobile Apps, Connected Devices, Services, Others
  • Application - Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Health, General Health and Wellness
  • End Users- Individuals, Hospitals, Diagnostic Centers, and Fertility Clinics

Regional Segmentation

  • North America - U.S., Canada
  • Europe -Germany, U.K., France, Spain, Netherlands, Sweden, Switzerland, Belgium
  • Asia-Pacific - China, Japan, India, South Korea, and Australia
  • Rest-of-the-World - Saudi Arabia, United Arab Emirates, Israel, South Africa, Brazil and Mexico

Growth Drivers

  • Growing recognition of Women in the Domain of Technology
  • Economic Burden of Women's health is more than $500 Billion
  • Explosion of wearable devices and increasing smartphone penetration among women

Market Challenges

  • Lack of women decision makers
  • Societal taboos surrounding women's health issues
  • Absence of awareness among women in rural areas
  • Lack of scientific studies to back industrial claims

Market Opportunities

  • Investment in product development for maternal, pre- and neo-natal care
  • Investment in sub-Saharan Africa
  • Product development for menopause management

Key Companies Profiled

ALYK, Inc., Aytu BioScience, Inc., Biowink GmbH, CORA, Flo Health, Inc., Bloomlife, Glow, Inc., Inne, Kasha, NaturalCycles Nordic AB, Plackal Tech, Ovia Health, Sustain Natural, The Flex Company, Thinx, Inc., Celmatix Inc., Conceivable Inc., Lia Diagnostics Inc., Lucina Health, Inc., Progny, Inc., Univfy Inc., among others

Key Questions Answered:

  • How has the market evolved in the last five years, and what are the awaited technological advancements in the field of Femtech?
  • What are the major market drivers, challenges, and opportunities in the global Femtech market?
  • What are the underlying structures resulting in the emerging trends within the Femtech industry?
  • What was the market value of the leading segments of the global Femtech market in 2019?
  • What are the influencing factors that may affect the market positioning of the key players?
  • How is industry expected to evolve during the forecast period 2019-2030?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What are the key business models employed by the femtech companies to standout in the evolving market?
  • What is the growth potential of Femtech in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What are the key regulatory implications in developed and developing regions for Femtech?
  • What was the funding trends for the Femtech companies in the last three years and how would the funding scenario change during the forecast period?

Market Overview

Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.

However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women centric start-ups have significantly multiplied in the recent years. This surge is also primarily attributed to the launch of fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.

Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering a financial support of $23 million.

As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period. One of the major driving factor for the market is increasing incidence of infectious and chronic diseases among the female population leading to surge in demand for effective and more personalized treatment. Furthermore, women's health awareness has significantly increased in recent years. For an instance, it was not until 2004, the cardiovascular diseases were considered medically a threat to women's health. However, campaigns such as the American Heart Association's Go Red for Women campaign and the NHLBI's Heart Truth program have significantly boosted the awareness related to life threatening diseases such as CVD.

Another reason driving the growth of the market is growing prevalence of infectious disease among females in low to middle-income countries due to an unhygienic environment. For an instance, in 2013, 60% of new HIV infections in population younger than 25 years occurred in girls and young women. Also, untreated syphilis in low- and middle-income countries still causes over 200 000 deaths every year.

However, some of the major challenges restraining the growth of the market are: creation of awareness among women, particularly in rural areas, unequal distribution of women as compared to men in investment community, and lack of understanding of women health issues by investors, among others.

Competitive Landscape

The Femtech market comprises over 200 start-ups worldwide, 92 percent of which are founded and led by women. Big names in these areas are developing entirely new solutions such as the Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker. While others focus on building tech platforms and subscription services to make existing products such as birth control and period products more easily accessible.

Although majority of Femtech firms are focusing on the millennials, there are also companies working for women at all ages. For example, Genneve, an online clinic aimed at aiding women entering menopause. Also, other companies such as Madorra and MenoGeni are developing devices and pharmaceutical alternatives to aid in the treatment of menopausal symptoms. Companies are extensively entering new women's health spaces to stand out in the competition. Some of the emerging women's heath spaces are osteoporosis, breast cancer, autoimmune conditions, stroke, thyroid issues, chronic fatigue, anxiety, and depression.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Scope of the Study

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Companies Profiled
  • 3.5 Assumptions and Limitations

4 Industry Analysis

  • 4.1 Industry Trends
    • 4.1.1 Underrepresentation of Women as Decision Makers
    • 4.1.2 Pricing and Branding Strategies
    • 4.1.3 Femtech in Emerging Economies
    • 4.1.4 Growing Emphasis on Holistic Women Healthcare
    • 4.1.5 Smart Medical Devices and Wearables
    • 4.1.6 Destigmatizing Menstrual Health and Menopause
  • 4.2 Femtech Innovation Tracker
    • 4.2.1 Wearable Devices for Fertility Tracking
    • 4.2.2 Vaginal Sensor for Fertility Cycle Monitoring
    • 4.2.3 Leveraging Genomics and Big Data for Fertility Tracking and Menstrual Health
    • 4.2.4 Wearables for Breast Cancer Screening
  • 4.3 Regulatory Framework
    • 4.3.1 Regulatory Framework in North America
    • 4.3.2 Regulatory Framework in Europe
  • 4.4 Funding Analysis
    • 4.4.1 Femtech Received More Than $1 Billion Over the Last 5 Years
    • 4.4.2 Notable Private Funding in Femtech

5 Competitive Landscape

  • 5.1 Key Developments and Strategies
    • 5.1.1 Funding
    • 5.1.2 Collaborations and Partnerships
    • 5.1.3 Product Launch and Upgradation
    • 5.1.4 Mergers and Acquisitions
  • 5.2 Business Model Analysis
    • 5.2.1 One-for-One Give Back Model
    • 5.2.2 Direct-to-Consumer
    • 5.2.3 Subscription
    • 5.2.4 Prescription Telemedicine Model
  • 5.3 Product Mapping Analysis

6 Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Growing Recognition of Women in the Domain of Technology
    • 6.1.2 Economic Burden by Women's Health is More Than $500 Billion
    • 6.1.3 Explosion of Wearable Devices and Increasing Smartphone Penetration Among Women
  • 6.2 Market Restraints
    • 6.2.1 Lack of Women Decision Makers
    • 6.2.2 Societal Taboos Surrounding Women's Health Issues
    • 6.2.3 Absence of Awareness Among Women in Rural Areas
    • 6.2.4 Lack of Scientific Studies to Back Industrial Claims
    • 6.2.5 Raising Capital and Workforce
    • 6.2.6 Product Marketing in Femtech Space
  • 6.3 Market Opportunities
    • 6.3.1 Investment in Product Development for Maternal, Pre- and Neo-Natal Care
    • 6.3.2 Investment in Sub-Saharan Africa
    • 6.3.3 Product Development for Menopause Management

7 Global Femtech Market

  • 7.1 Assumptions and Limitations
  • 7.2 Key Findings and Opportunity Assessment
    • 7.2.1 Key Findings
    • 7.2.2 Opportunity Assessment

8 Global Femtech Market (by Component)

  • 8.1 Overview
  • 8.2 Mobile Apps
  • 8.3 Connected Devices
    • 8.3.1 Wearable Connected Device
    • 8.3.2 Non-Wearable Connected Device
  • 8.4 Services
  • 8.5 Others (Organic, Smart Female Hygiene Products)

9 Global Femtech Market (by Application)

  • 9.1 Overview
  • 9.2 Reproductive Health
    • 9.2.1 Period Tracking
    • 9.2.2 At-Home Fertility Tracking and Monitoring
  • 9.3 General Wellness
      • 9.3.1.1 Menopause
  • 9.4 Pregnancy and Nursing Care
    • 9.4.1 Pregnancy Care
    • 9.4.2 Post Pregnancy Care
      • 9.4.2.1 Post-Partum Depression
    • 9.4.3 Breastfeeding
    • 9.4.4 Others
  • 9.5 Pelvic and Uterine Care
    • 9.5.1 Pelvic Wellness
    • 9.5.2 Menstrual Health

10 Global Femtech Market (by End User)

  • 10.1 Overview
  • 10.2 Individuals
  • 10.3 Fertility Clinics
  • 10.4 Hospitals and Research Institutes
  • 10.5 Diagnostic Centers

11 Global Femtech Market (By Region)

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 Sweden
    • 11.3.4 Spain
    • 11.3.5 France
    • 11.3.6 Netherlands
    • 11.3.7 Rest-of-Europe
      • 11.3.7.1 Switzerland
      • 11.3.7.2 Belgium
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 South Korea
    • 11.4.4 Australia
    • 11.4.5 India
    • 11.4.6 Rest-of-Asia-Pacific
      • 11.4.6.1 New Zealand
  • 11.5 Middle East, South Africa, and Latin America
    • 11.5.1 Middle East
      • 11.5.1.1 Israel
      • 11.5.1.2 Saudi Arabia
      • 11.5.1.3 UAE
    • 11.5.2 South Africa
    • 11.5.3 Latin America
      • 11.5.3.1 Brazil
      • 11.5.3.2 Mexico
    • 11.5.4 Rest-of-Rest -of-the-World (Rest-of-RoW)

12 Company Profiles

  • 12.1 Overview
  • 12.2 ALYK, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Role of ALYK, Inc. in the Global Femtech Market
    • 12.2.3 Recent Developments
    • 12.2.4 SWOT Analysis: ALYK, Inc.
  • 12.3 Aytu BioScience, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of Aytu Bioscience, Inc. in the Global Femtech Market
    • 12.3.3 Financials
    • 12.3.4 Key Insights About Financial Health of the Company
    • 12.3.5 Recent Developments
    • 12.3.6 SWOT Analysis
  • 12.4 Biowink GmbH
    • 12.4.1 Company Overview
    • 12.4.2 Role of Biowink GmbH in the Global Femtech Market
    • 12.4.3 Recent Developments
    • 12.4.4 SWOT Analysis: Biowink GmbH
  • 12.5 Bloomlife
    • 12.5.1 Company Overview
    • 12.5.2 Role of Bloomlife GmbH in the Global Femtech Market
    • 12.5.3 Recent Developments
    • 12.5.4 SWOT Analysis: Bloomlife
  • 12.6 CORA
    • 12.6.1 Company Overview
    • 12.6.2 Role of CORA in the Global Femtech Market
    • 12.6.3 Recent Developments
    • 12.6.4 SWOT Analysis: CORA
  • 12.7 Flo Health, Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Role of Flo Health Inc. in the Global Femtech Market
    • 12.7.3 Recent Developments
    • 12.7.4 SWOT Analysis: Flo Health Inc.
  • 12.8 Glow, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of Glow, Inc. in the Global Femtech Market
    • 12.8.3 Recent Developments
    • 12.8.4 SWOT Analysis: Glow, Inc.
  • 12.9 Inne
    • 12.9.1 Company Overview
    • 12.9.2 Role of Inne in the Global Femtech Market
    • 12.9.3 Recent Developments
    • 12.9.4 SWOT Analysis: Inne.
  • 12.10 Kasha
    • 12.10.1 Company Overview
    • 12.10.2 Role of Kasha in the Global Femtech Market
    • 12.10.3 Recent Developments
    • 12.10.4 SWOT Analysis: Kasha
  • 12.11 NaturalCycles Nordic AB
    • 12.11.1 Company Overview
    • 12.11.2 Role of NaturalCycles Nordic AB in the Global Femtech Market
    • 12.11.3 Recent Developments
    • 12.11.4 SWOT Analysis: NaturalCycels Nordic AB
  • 12.12 Ovia Health
    • 12.12.1 Company Overview
    • 12.12.2 Role of Ovia Health Inc. in the Global Femtech Market
    • 12.12.3 Recent Developments
    • 12.12.4 SWOT Analysis: Ovia Health
  • 12.13 Plackal Tech
    • 12.13.1 Company Overview
    • 12.13.2 Role of Plackal Tech in the Global Femtech Market
    • 12.13.3 Recent Developments
    • 12.13.4 SWOT Analysis: Plackal Tech.
  • 12.14 Sustain Natural
    • 12.14.1 Company Overview
    • 12.14.2 Role of Sustain Natural in the Global Femtech Market
    • 12.14.3 Recent Developments
    • 12.14.4 SWOT Analysis: Sustain Natural
  • 12.15 The Flex Company
    • 12.15.1 Company Overview
    • 12.15.2 Role of The Flex Company in the Global Femtech Market
    • 12.15.3 Recent Developments
    • 12.15.4 SWOT Analysis: The Flex Company
  • 12.16 Thinx, Inc.
    • 12.16.1 Company Overview
    • 12.16.2 Role of Thinx Inc. in the Global Femtech Market
    • 12.16.3 Recent Developments
    • 12.16.4 SWOT Analysis: Thinx Inc.
  • 12.17 Company Snapshots
    • 12.17.1 Celmatix Inc.
      • 12.17.1.1 Company Overview
      • 12.17.1.2 Role of Celmatix Inc. in the Global Femtech Market
    • 12.17.2 Conceivable Inc.
      • 12.17.2.1 Company Overview
      • 12.17.2.2 Role of Conceivable Inc. in the Global Femtech Market
    • 12.17.3 Lia Diagnostics Inc.
      • 12.17.3.1 Company Overview
      • 12.17.3.2 Role of Lia Diagnostics Inc. in the Global Femtech Market
    • 12.17.4 Lucina Health, Inc. (Subsidiary of Unified Women's Healthcare, LLC)
      • 12.17.4.1 Company Overview
      • 12.17.4.2 Role of Lucina Health, Inc. in the Global Femtech Market
    • 12.17.5 Progny, Inc.
      • 12.17.5.1 Company Overview
      • 12.17.5.2 Role of Progny, Inc. in the Global Femtech Market
    • 12.17.6 Univfy Inc.
      • 12.17.6.1 Company Overview
      • 12.17.6.2 Role of Univfy Inc. in the Global Femtech Market
Back to Top
전화 문의
F A Q